Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Harriet Stavert

1PUBLICATIONS

16CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 25, 2023

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.

Peter A Henriksen, Peter Hall, Iain R MacPherson

Pageof 1

Frequent Collaborators

1 joint publications

Peter Hall

1 joint publications

Iain R MacPherson

1 joint publications

Morag Maclean

1 joint publications

Steff Lewis

1 joint publications

Aryelly Rodriguez

1 joint publications

Alex Fletcher

1 joint publications

Heather McVicars

1 joint publications

Pam McKay

1 joint publications

Annabel Borley

1 joint publications

Simon Lord

Frequent Collaborators

1 joint publications

Peter Hall

1 joint publications

Iain R MacPherson

1 joint publications

Morag Maclean

1 joint publications

Steff Lewis

Top Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on : Mar 24, 2023

See more related videos

Top Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on : Mar 24, 2023

See more related videos